Pennsylvania Bill caps insulin copayments at thirty-five dollars and mandates Attorney General pricing investigation

Pennsylvania health insurance policies providing prescription coverage for insulin are prohibited from charging more than thirty-five dollars per thirty-day supply for a covered individual, regardless of the amount or type needed. The legislation also requires the Attorney General to investigate insulin manufacturing and pricing practices and submit a public report to the General Assembly within one year. These changes take effect in 60 days.

Insulin-dependent residents enrolled in covered health plans will see direct out-of-pocket cost limits on their monthly prescriptions, while state regulators gain explicit authority to review drug pricing practices.

• ›The Insurance Company Law of 1921 is the foundational statute governing insurance companies operating within the Commonwealth of Pennsylvania. context
• ›Legislative proposals capping insulin out-of-pocket costs have been introduced in multiple states in response to rising prices for diabetes management medications. context